Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS

ClinicalTrials.gov ID: NCT05196828

Public ClinicalTrials.gov record NCT05196828. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 7:35 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Extension Study to Evaluate Longer-Duration Response to the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Multi-center, prospective open-label extension study of noninvasive peripheral nerve stimulation (NPNS) with the NTX100 Neuromodulation System for patients with medication-refractory moderate- severe primary RLS

Study identification

NCT ID
NCT05196828
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Noctrix Health, Inc.
Industry
Enrollment
103 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
22 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2021 (Actual)
Primary completion
Sep 27, 2022 (Actual)
Completion
Nov 18, 2022 (Actual)
Last update posted
Sep 19, 2024

2021 – 2022

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
California Center for Sleep Disorders San Leandro California 94578 —
Delta Waves, Inc. Colorado Springs Colorado 95125 —
Neurotrials Research Atlanta Georgia 30328 —
Clayton Sleep Institute St Louis Missouri 63123 —
Ohio Sleep Medicine Institute Dublin Ohio 43017 —
Bogan Sleep Consultants, LLC Columbia South Carolina 29201 —
FutureSearch Trials of Neurology Austin Texas 78731 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05196828, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2024 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05196828 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →